Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
MURPHY ANDREW J
EVP Research at Regeneron Pharmaceuticals. Filing since 27 Jan 2020.
CIK 0001796226
Company
Date
Role
Action
Shares
Amount
Of holding
REGN
Regeneron Pharmaceuticals
14 Aug 2024
EVP Research
Sold on a plan
6,363
$7.34M
11.6%
REGN
Regeneron Pharmaceuticals
14 Mar 2024
EVP Research
Sold on a plan
5,783
$5.53M
10.7%
REGN
Regeneron Pharmaceuticals
5 Dec 2023
EVP Research
Sold on a plan
6,536
$5.34M
9.9%
REGN
Regeneron Pharmaceuticals
14 Nov 2023
EVP Research
Sold on a plan
6,492
$5.19M
9.8%
REGN
Regeneron Pharmaceuticals
15 Nov 2022
EVP Research
Sold, plan not stated
3,720
$2.71M
6.1%
REGN
Regeneron Pharmaceuticals
16 Aug 2022
EVP Research
Sold, plan not stated
3,513
$2.27M
5.7%
REGN
Regeneron Pharmaceuticals
17 May 2022
EVP Research
Sold, plan not stated
3,543
$2.35M
5.7%
REGN
Regeneron Pharmaceuticals
15 Feb 2022
EVP Research
Sold, plan not stated
3,540
$2.23M
5.7%
REGN
Regeneron Pharmaceuticals
10 Dec 2021
EVP Research
Sold, plan not stated
7,122
$4.75M
10.7%
REGN
Regeneron Pharmaceuticals
16 Nov 2021
EVP Research
Sold, plan not stated
7,167
$4.64M
11.4%
REGN
Regeneron Pharmaceuticals
17 Nov 2020
EVP Research
Sold, plan not stated
6,628
$3.60M
12.3%
REGN
Regeneron Pharmaceuticals
14 Jul 2020
EVP Research
Sold, plan not stated
6,309
$3.96M
13.1%
REGN
Regeneron Pharmaceuticals
13 Jul 2020
EVP Research
Sold, plan not stated
8,000
$5.03M
16.0%
REGN
Regeneron Pharmaceuticals
27 Jan 2020
EVP Research
Sold, plan not stated
8,000
$2.73M
13.8%
14 decisions on file.
